An Overview of MicroRNAs as Biomarkers of ALS
Amyotrophic lateral sclerosis (ALS; MND, motor neuron disease) is a debilitating neurodegenerative disease affecting 4.5 per 100,000 people per year around the world. There is currently no cure for this disease, and its causes are relatively unknown. Diagnosis is based on a battery of clinical tests...
Main Authors: | Greig Joilin, P. Nigel Leigh, Sarah F. Newbury, Majid Hafezparast |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00186/full |
Similar Items
-
Corrigendum: An Overview of MicroRNAs as Biomarkers of ALS
by: Greig Joilin, et al.
Published: (2019-10-01) -
Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis
by: Eleni Christoforidou, et al.
Published: (2020-04-01) -
Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients
by: Greig Joilin, et al.
Published: (2022-12-01) -
MicroRNA-5572 Is a Novel MicroRNA-Regulating <i>SLC30A3</i> in Sporadic Amyotrophic Lateral Sclerosis
by: Hisaka Kurita, et al.
Published: (2020-06-01) -
The involvement of microRNAs in neurodegenerative diseases
by: Simona eMaciotta Rolandin, et al.
Published: (2013-12-01)